Abstract
Inflammatory bowel disease (IBD) is a group of inflammatory and immune-mediated disorders principally affecting the gastrointestinal tract. Crohn’s disease (CD) and ulcerative colitis (UC) comprise the two main types of IBD. It is mainly a disease of the Western world probably due to the impact of lifestyle, but in the recent years the incidence of these diseases has been increasing worldwide due to the influence of several other factors. The genetic predisposition, immune mechanisms leading to the immune system reacting against their own body called autoimmunity, alterations in the intestinal bacterial flora, and the influence of several environmental factors either singly or in combination have been postulated as the reasons for developing IBD. Several of these genetic factors and immune mechanisms are being studied currently leading to advancement in treatment strategies. IBD not only causes gastrointestinal symptoms but can also affect several extraintestinal organs, thus affecting the quality of life to a large extent. Thus IBD can present in various ways in individuals, and hence a deeper understanding of the pathophysiology and disease mechanism is essential.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46.
Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599.
Wyatt J, Vogelsang H, Hübl W, et al. Intestinal permeability and the prediction of relapse in Crohn’s disease. Lancet. 1993;341:1437.
Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology. 1998;115:822.
Diveu C, McGeachy MJ, Cua DJ. Cytokines that regulate autoimmunity. Curr Opin Immunol. 2008;20:663.
Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2014;380(9853):1590–605.
Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol. 2006;20:451.
Farhi D, Cosnes J, Zizi N, et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore). 2008;87:281.
Rasmussen HH, Fallingborg JF, Mortensen PB, et al. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn’s disease. Scand J Gastroenterol. 1997;32:604.
Irving PM, Pasi KJ, Rampton DS. Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol. 2005;3:617.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Thoguluva Chandrasekar, V., Venu, N. (2015). So What Is Crohn’s Disease and Ulcerative Colitis? Pathophysiology of Crohn’s Disease and Ulcerative Colitis. In: Stein, D., Shaker, R. (eds) Inflammatory Bowel Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-14072-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-14072-8_3
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14071-1
Online ISBN: 978-3-319-14072-8
eBook Packages: MedicineMedicine (R0)